A biotech leader with deep experience across gene therapy, platform innovation, and company-building. He was apart of the team that helped bring one of the first ex vivo gene therapies to market.

A key figure in the environmental services sector, Chris has led Alliance’s transformation from a two-person source testing business into North America’s largest stack testing company.

CEO of AltruBio—one of the most exciting biotech companies out there, especially after closing the largest Series B in biotech over the last four years.

CEO and Co-founder of Arx Nimbus. Discover how traditional risk assessments are being transformed through quantitative analysis, and learn about the real-world impact of these innovations on global enterprises.

I sit down with Dr. Jan-Hendrik Rutsch, COO of Tentamus Group, to uncover the intricacies of the Testing, Inspection, and Certification (TIC) industry.